From: Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
BDP/F extrafine pMDI (n = 20)
BUD/F and FP/S DPI (n = 19)
All (n = 39)
Controlled
12 (60%)
8 (42.1%)
20 (51.3)
Partially controlled
5 (25%)
5 (26.3%)
10 (25.6%)
Uncontrolled
3 (15%)
6 (31.6%)
9 (23.1%)